SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 135 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $470,000 | -50.3% | 42,770 | -38.7% | 0.14% | -50.7% |
Q4 2016 | $945,000 | +39.4% | 69,770 | +26.7% | 0.28% | +44.6% |
Q3 2016 | $678,000 | -59.4% | 55,070 | -43.0% | 0.20% | -58.4% |
Q4 2015 | $1,671,000 | +27.4% | 96,630 | +46.3% | 0.47% | +22.8% |
Q3 2015 | $1,312,000 | +277.0% | 66,053 | +211.6% | 0.38% | +315.2% |
Q2 2015 | $348,000 | -5.9% | 21,200 | -10.9% | 0.09% | -11.5% |
Q1 2015 | $370,000 | -51.4% | 23,800 | -55.3% | 0.10% | -54.2% |
Q4 2014 | $761,000 | +126.5% | 53,300 | +3.1% | 0.23% | +146.7% |
Q3 2014 | $336,000 | -39.7% | 51,700 | -35.9% | 0.09% | -32.8% |
Q2 2014 | $557,000 | -17.1% | 80,700 | -14.1% | 0.14% | -2.8% |
Q1 2014 | $672,000 | +34.9% | 94,000 | +77.4% | 0.14% | +16.5% |
Q4 2013 | $498,000 | – | 53,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 555,652 | $9,607,000 | 3.06% |
OBERWEIS ASSET MANAGEMENT INC/ | 96,630 | $1,671,000 | 0.47% |
JUNCTURE WEALTH STRATEGIES, LLC | 35,281 | $610,000 | 0.46% |
AWM Investment Company, Inc. | 100,000 | $1,729,000 | 0.34% |
GLOBEFLEX CAPITAL L P | 65,588 | $1,134,000 | 0.30% |
NEW AMSTERDAM PARTNERS LLC/NY | 166,479 | $2,878,000 | 0.30% |
Convergence Investment Partners, LLC | 100,850 | $1,744,000 | 0.20% |
GSA CAPITAL PARTNERS LLP | 219,881 | $3,802,000 | 0.19% |
OXFORD ASSET MANAGEMENT LLP | 433,219 | $7,672,000 | 0.18% |
Zebra Capital Management LLC | 17,720 | $306,000 | 0.17% |